Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepacivirus | 1 | 2017 | 1378 | 0.360 |
Why?
|
| Multiple Sclerosis | 4 | 2022 | 3079 | 0.290 |
Why?
|
| Genotype | 3 | 2023 | 12944 | 0.260 |
Why?
|
| Papillomavirus Infections | 3 | 2023 | 1587 | 0.230 |
Why?
|
| Lacrimal Duct Obstruction | 1 | 2022 | 48 | 0.210 |
Why?
|
| Italy | 3 | 2020 | 829 | 0.210 |
Why?
|
| Dacryocystitis | 1 | 2022 | 70 | 0.210 |
Why?
|
| Nasolacrimal Duct | 1 | 2022 | 74 | 0.210 |
Why?
|
| Varicocele | 1 | 2022 | 77 | 0.200 |
Why?
|
| Papillomaviridae | 2 | 2023 | 1119 | 0.150 |
Why?
|
| Quinine | 2 | 2006 | 54 | 0.140 |
Why?
|
| Human papillomavirus 31 | 1 | 2014 | 2 | 0.130 |
Why?
|
| Theonella | 1 | 2011 | 1 | 0.110 |
Why?
|
| Embolization, Therapeutic | 1 | 2022 | 1392 | 0.100 |
Why?
|
| Glycosides | 1 | 2011 | 107 | 0.100 |
Why?
|
| Hepatitis C, Chronic | 1 | 2017 | 1029 | 0.090 |
Why?
|
| Vaccines, Synthetic | 2 | 2022 | 634 | 0.080 |
Why?
|
| Aminolevulinic Acid | 1 | 2008 | 142 | 0.080 |
Why?
|
| Tuberculosis | 1 | 2020 | 1914 | 0.080 |
Why?
|
| Human papillomavirus 16 | 2 | 2023 | 261 | 0.070 |
Why?
|
| Antifungal Agents | 1 | 2011 | 729 | 0.070 |
Why?
|
| Health Personnel | 1 | 2020 | 3217 | 0.070 |
Why?
|
| Prodrugs | 1 | 2008 | 263 | 0.070 |
Why?
|
| Antibodies, Viral | 3 | 2022 | 3175 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 2022 | 13028 | 0.070 |
Why?
|
| Immunoglobulin G | 3 | 2022 | 4561 | 0.070 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2006 | 66 | 0.070 |
Why?
|
| Dysentery, Bacillary | 1 | 2005 | 75 | 0.060 |
Why?
|
| Herpes Simplex | 1 | 2008 | 470 | 0.060 |
Why?
|
| Shigella flexneri | 1 | 2005 | 132 | 0.060 |
Why?
|
| Photosensitizing Agents | 1 | 2008 | 602 | 0.060 |
Why?
|
| Typhoid Fever | 1 | 2005 | 197 | 0.060 |
Why?
|
| Staphylococcal Protein A | 1 | 2003 | 40 | 0.060 |
Why?
|
| Salmonella typhimurium | 1 | 2005 | 351 | 0.060 |
Why?
|
| Porins | 1 | 2003 | 81 | 0.060 |
Why?
|
| Teichoic Acids | 1 | 2003 | 66 | 0.060 |
Why?
|
| Herpesvirus 1, Human | 1 | 2008 | 743 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2017 | 6535 | 0.050 |
Why?
|
| Photochemotherapy | 1 | 2008 | 808 | 0.050 |
Why?
|
| Antimalarials | 2 | 2006 | 904 | 0.050 |
Why?
|
| Sclerosing Solutions | 1 | 2022 | 78 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 1 | 2003 | 317 | 0.050 |
Why?
|
| Virus Replication | 1 | 2008 | 2535 | 0.050 |
Why?
|
| Semen Analysis | 1 | 2022 | 204 | 0.050 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2003 | 1159 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2022 | 3758 | 0.040 |
Why?
|
| Spermatozoa | 1 | 2022 | 618 | 0.040 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2003 | 1121 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2003 | 2217 | 0.030 |
Why?
|
| Humans | 15 | 2023 | 743811 | 0.030 |
Why?
|
| Adult | 6 | 2023 | 213889 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2003 | 2500 | 0.030 |
Why?
|
| Prevalence | 2 | 2023 | 15211 | 0.030 |
Why?
|
| Human papillomavirus 18 | 1 | 2014 | 128 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2003 | 4162 | 0.030 |
Why?
|
| Apoptosis | 1 | 2008 | 9718 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2023 | 77410 | 0.020 |
Why?
|
| Students | 1 | 2020 | 1647 | 0.020 |
Why?
|
| Female | 6 | 2023 | 380020 | 0.020 |
Why?
|
| Microbial Viability | 1 | 2011 | 234 | 0.020 |
Why?
|
| Male | 4 | 2023 | 349776 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 3275 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 7719 | 0.020 |
Why?
|
| Middle Aged | 3 | 2019 | 213241 | 0.020 |
Why?
|
| Cytokines | 1 | 2003 | 7324 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2008 | 442 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 3128 | 0.020 |
Why?
|
| Sex Factors | 1 | 2019 | 10394 | 0.020 |
Why?
|
| Young Adult | 2 | 2023 | 56392 | 0.020 |
Why?
|
| Mass Screening | 1 | 2020 | 5251 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2008 | 796 | 0.020 |
Why?
|
| Disease Progression | 2 | 2014 | 13273 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6539 | 0.010 |
Why?
|
| I-kappa B Proteins | 1 | 2003 | 225 | 0.010 |
Why?
|
| Autocrine Communication | 1 | 2003 | 171 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5319 | 0.010 |
Why?
|
| Paracrine Communication | 1 | 2003 | 278 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2008 | 1899 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2003 | 690 | 0.010 |
Why?
|
| Cell Division | 1 | 2006 | 4568 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2003 | 3144 | 0.010 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2003 | 1212 | 0.010 |
Why?
|
| Malaria | 1 | 2005 | 1239 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 35409 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2022 | 63042 | 0.010 |
Why?
|
| Bacteria | 1 | 2006 | 2112 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2003 | 2615 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2003 | 1986 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2003 | 1453 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2006 | 2542 | 0.010 |
Why?
|
| Cell Line | 1 | 2008 | 15993 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2003 | 3208 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 72252 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 8436 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 4422 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 85729 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 19232 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 16674 | 0.010 |
Why?
|
| Skin | 1 | 2003 | 4372 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2006 | 6363 | 0.010 |
Why?
|
| Inflammation | 1 | 2003 | 10629 | 0.000 |
Why?
|
| Animals | 1 | 2011 | 168660 | 0.000 |
Why?
|
Concepts
(102)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_